Medesis Pharma SA (ALMDP) — Defensive Interval Ratio
Medesis Pharma SA (ALMDP) has a Defensive Interval Ratio of 0 days as of June 2024. Defensive assets of €4.54K (cash €-, short-term investments €-, receivables €4.54K) cover 0 days of daily cash needs of €10.44K/day. See Medesis Pharma SA (ALMDP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Medesis Pharma SA Defensive Interval Ratio (2018–2023)
This chart shows how Medesis Pharma SA's Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the ratio stands at 0 days, meaning defensive assets of €4.54K can fund 0 days of operations without new revenue. See ALMDP equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Medesis Pharma SA (2018–2023)
The table below presents the year-by-year Defensive Interval Ratio for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Medesis Pharma SA (ALMDP) total market value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 40 days | €439.20K | €11.10K/day | €- | €-28.50K | ▲ +7 days |
| 2022 | 32 days | €170.59K | €5.29K/day | €- | €- | ▼ -1168 days |
| 2021 | 1200 days | €5.66 Million | €4.71K/day | €2.89 Million | €2.70 Million | ▲ +1119 days |
| 2020 | 81 days | €441.34K | €5.44K/day | €65.45K | €- | ▼ -240 days |
| 2019 | 321 days | €458.00K | €1.43K/day | €75.00K | €- | ▲ +260 days |
| 2018 | 61 days | €95.00K | €1.55K/day | €95.00K | €- | — |